EVIDENCE meta-analysis: evaluating minimal residual disease as an intermediate clinical end point for multiple myeloma - Landgren, Ola; Prior, Thomas J.; Masterson, Tara; Heuck, Christoph; Bueno, Orlando F.; Dash, Ajeeta B.; Einsele, Hermann; Goldschmidt, Hartmut; Knop, Stefan; Li, Cong; Mellqvist, Ulf-Henrik; McFadden, Ian; et al. (Blood, 2024)
Online veröffentlicht: 20. Mai 2024